1 Rodriguez, A. D., "Two bromotyrosine-cysteine derived metabolites from a sponge" 28 : 4989-, 1987
2 Baud, M. G., "Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors" 9 : 81-, 2013
3 Yang, X., "Targeting DNA methylation for epigenetic therapy" 31 : 536-, 2010
4 Wen, J., "Synthesis, biological evaluation and histone deacetylase inhibiting as cytotoxic agents" 26 : 4372-, 2016
5 Asgatay, S., "Synthesis and evaluation of analogues of Nphthaloyl-L-tryptophan (RG 108) as inhibitors of DNA methyltransferase 1" 57 : 421-, 2013
6 Chik, F., "Role of epigenetics in cancer initiation and progression" 720 : 91-, 2011
7 Halby, L., "Rapid synthesis of new DNMT inhibitors derivatives of procainamide" 13 : 157-, 2012
8 Piña, I. C., "Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase" 68 : 3866-, 2003
9 Kim, D., "Psammaplin A, a natural phenolic compound has inhibitory effect on human topoisomerase II and its cytotoxic to cancer cells" 19 : 4085-, 1999
10 Lee, B. H., "Procainamide is a specific inhibitor of DNA methyltransferase 1" 280 : 40749-, 2005
1 Rodriguez, A. D., "Two bromotyrosine-cysteine derived metabolites from a sponge" 28 : 4989-, 1987
2 Baud, M. G., "Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors" 9 : 81-, 2013
3 Yang, X., "Targeting DNA methylation for epigenetic therapy" 31 : 536-, 2010
4 Wen, J., "Synthesis, biological evaluation and histone deacetylase inhibiting as cytotoxic agents" 26 : 4372-, 2016
5 Asgatay, S., "Synthesis and evaluation of analogues of Nphthaloyl-L-tryptophan (RG 108) as inhibitors of DNA methyltransferase 1" 57 : 421-, 2013
6 Chik, F., "Role of epigenetics in cancer initiation and progression" 720 : 91-, 2011
7 Halby, L., "Rapid synthesis of new DNMT inhibitors derivatives of procainamide" 13 : 157-, 2012
8 Piña, I. C., "Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase" 68 : 3866-, 2003
9 Kim, D., "Psammaplin A, a natural phenolic compound has inhibitory effect on human topoisomerase II and its cytotoxic to cancer cells" 19 : 4085-, 1999
10 Lee, B. H., "Procainamide is a specific inhibitor of DNA methyltransferase 1" 280 : 40749-, 2005
11 Holleran, J. L., "Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine" 11 : 3862-, 2005
12 Quinoa, E., "Phenolic constituents of Psammaplysilla" 28 : 3229-, 1987
13 Yoo, J., "Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: Implications for the mechanism of inhibition of DNMTs" 8 : e62152-, 2013
14 Stresman, C., "Modes of action of the DNA methyltransferase inhibitors, azacytidine and decitabine" 125 : 8-, 2008
15 Ben-Kasus, T., "Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells" 70 : 121-, 2005
16 Yoo, C. B., "Epigenetic therapy of cancer: Past, present and future" 5 : 37-, 2006
17 Garcia, J., "Epigenetic profiling of the antitumor natural product psammaplin A and its analogues" 19 : 3637-, 2011
18 Weber, M., "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome" 39 : 457-, 2007
19 Wang, S. -C., "Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential" 62 : 5625-, 2014
20 Graça, I., "Antitumoral effect of the non-nucleoside DNMT inhibitor RG-108 in human prostate cancer cells" 20 : 1803-, 2014
21 Berger, S. L., "An operational definition of epigenetics" 23 : 781-, 2009
22 Gadat, A. M., "An Improved synthesis of psammaplin A" 16 : 3330-, 2006
23 Yamanaka, M., "Altered methylation of multiple genes in carcinogenesis of the prostate" 106 : 382-, 2003
24 Hoshino, O., "A convenient synthesis of a bromotyrosine derived metabolite psammaplin A, from psammaphysilla sp" 2 : 1561-, 1992
25 Christman, J. K., "5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitor of DNA methylation: mechanistic studies and their implications for cancer therapy" 21 : 5483-, 2002